SEP 8, 2026 · PHASE 2/3 TRIAL
Midodrine in Heart Failure With Reduced Ejection Fraction With Hypotension
ClinicalTrials.gov
This is a Phase 2/3 feasibility and safety trial in recruitment with no results posted; the registry documents a study designed to establish proof-of-concept in a previously unstudied population.
Reported
Estimated enrollment56
Study phasePHASE 2, PHASE 3
Enrollment assessment periodup to 80 weeks (20 months)